SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials).
D000284:Administration, Oral; D000328:Adult; D001007:Anxiety / Q000188:drug therapy*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003201:Computers; D004569:Electroencephalography; D004827:Epilepsy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use; D007659:Ketones / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001552:Benzazepines; D006846:Hydrocarbons, Halogenated; D007659:Ketones; D014149:Tranquilizing Agents